vs
PUMA BIOTECHNOLOGY, INC.（PBYI）与Perma-Pipe International Holdings, Inc.（PPIH）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是Perma-Pipe International Holdings, Inc.的1.2倍（$75.5M vs $61.1M），Perma-Pipe International Holdings, Inc.同比增速更快（47.1% vs 27.7%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $12.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 23.4%）
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
Perma-Pipe International Holdings是一家专业研发、生产、销售预绝缘管道系统及一体化泄漏检测解决方案的企业，产品覆盖油气、区域冷暖、工业、市政基建等领域，业务遍布北美、中东、欧洲、亚洲等全球市场。
PBYI vs PPIH — 直观对比
营收规模更大
PBYI
是对方的1.2倍
$61.1M
营收增速更快
PPIH
高出19.4%
27.7%
自由现金流更多
PBYI
多$2.0M
$12.4M
两年增速更快
PBYI
近两年复合增速
23.4%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $75.5M | $61.1M |
| 净利润 | — | $6.3M |
| 毛利率 | 69.3% | 34.4% |
| 营业利润率 | 22.7% | 18.6% |
| 净利率 | — | 10.3% |
| 营收同比 | 27.7% | 47.1% |
| 净利润同比 | — | 153.5% |
| 每股收益（稀释后） | $0.26 | $0.77 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBYIPPIH
| Q4 25 | $75.5M | $61.1M | ||
| Q3 25 | $54.5M | $47.9M | ||
| Q2 25 | $52.4M | $46.7M | ||
| Q1 25 | $46.0M | $45.0M | ||
| Q4 24 | $59.1M | $41.6M | ||
| Q3 24 | $80.5M | $37.5M | ||
| Q2 24 | $47.1M | $34.3M | ||
| Q1 24 | $43.8M | $40.2M |
净利润PBYIPPIH
| Q4 25 | — | $6.3M | ||
| Q3 25 | $8.8M | $851.0K | ||
| Q2 25 | $5.9M | $5.0M | ||
| Q1 25 | $3.0M | $1.8M | ||
| Q4 24 | — | $2.5M | ||
| Q3 24 | $20.3M | $3.3M | ||
| Q2 24 | $-4.5M | $1.4M | ||
| Q1 24 | $-4.8M | $8.6M |
毛利率PBYIPPIH
| Q4 25 | 69.3% | 34.4% | ||
| Q3 25 | 77.7% | 30.1% | ||
| Q2 25 | 76.5% | 35.8% | ||
| Q1 25 | 77.1% | 33.7% | ||
| Q4 24 | 76.4% | 33.9% | ||
| Q3 24 | 63.9% | 35.9% | ||
| Q2 24 | 77.4% | 30.6% | ||
| Q1 24 | 75.5% | 30.0% |
营业利润率PBYIPPIH
| Q4 25 | 22.7% | 18.6% | ||
| Q3 25 | 17.6% | 6.7% | ||
| Q2 25 | 12.7% | 16.9% | ||
| Q1 25 | 8.7% | 12.1% | ||
| Q4 24 | 22.6% | 13.4% | ||
| Q3 24 | 27.4% | 16.4% | ||
| Q2 24 | -4.6% | 9.1% | ||
| Q1 24 | -5.3% | 11.3% |
净利率PBYIPPIH
| Q4 25 | — | 10.3% | ||
| Q3 25 | 16.2% | 1.8% | ||
| Q2 25 | 11.2% | 10.6% | ||
| Q1 25 | 6.5% | 3.9% | ||
| Q4 24 | — | 6.0% | ||
| Q3 24 | 25.2% | 8.8% | ||
| Q2 24 | -9.6% | 4.2% | ||
| Q1 24 | -11.0% | 21.5% |
每股收益（稀释后）PBYIPPIH
| Q4 25 | $0.26 | $0.77 | ||
| Q3 25 | $0.17 | $0.10 | ||
| Q2 25 | $0.12 | $0.61 | ||
| Q1 25 | $0.06 | $0.23 | ||
| Q4 24 | $0.40 | $0.31 | ||
| Q3 24 | $0.41 | $0.40 | ||
| Q2 24 | $-0.09 | $0.18 | ||
| Q1 24 | $-0.10 | $1.07 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | $27.2M |
| 总债务越低越好 | $22.7M | $12.7M |
| 股东权益账面价值 | $130.3M | $85.8M |
| 总资产 | $216.3M | $217.0M |
| 负债/权益比越低杠杆越低 | 0.17× | 0.15× |
8季度趋势，按日历期对齐
现金及短期投资PBYIPPIH
| Q4 25 | $97.5M | $27.2M | ||
| Q3 25 | $94.4M | $17.3M | ||
| Q2 25 | $96.0M | $18.8M | ||
| Q1 25 | $93.2M | $15.7M | ||
| Q4 24 | $101.0M | $13.3M | ||
| Q3 24 | $96.7M | $9.5M | ||
| Q2 24 | $96.8M | $7.7M | ||
| Q1 24 | $107.2M | $5.8M |
总债务PBYIPPIH
| Q4 25 | $22.7M | $12.7M | ||
| Q3 25 | $34.0M | — | ||
| Q2 25 | $45.3M | — | ||
| Q1 25 | $56.7M | $15.2M | ||
| Q4 24 | $68.0M | — | ||
| Q3 24 | $79.3M | — | ||
| Q2 24 | $90.7M | — | ||
| Q1 24 | $102.0M | $15.2M |
股东权益PBYIPPIH
| Q4 25 | $130.3M | $85.8M | ||
| Q3 25 | $115.3M | $80.2M | ||
| Q2 25 | $104.7M | $77.9M | ||
| Q1 25 | $97.1M | $72.1M | ||
| Q4 24 | $92.1M | $71.2M | ||
| Q3 24 | $71.1M | $68.6M | ||
| Q2 24 | $48.5M | $65.5M | ||
| Q1 24 | $51.0M | $65.7M |
总资产PBYIPPIH
| Q4 25 | $216.3M | $217.0M | ||
| Q3 25 | $202.9M | $189.0M | ||
| Q2 25 | $194.9M | $178.3M | ||
| Q1 25 | $196.2M | $165.2M | ||
| Q4 24 | $213.3M | $160.7M | ||
| Q3 24 | $220.7M | $157.8M | ||
| Q2 24 | $205.0M | $155.7M | ||
| Q1 24 | $214.1M | $155.7M |
负债/权益比PBYIPPIH
| Q4 25 | 0.17× | 0.15× | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.58× | 0.21× | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 1.12× | — | ||
| Q2 24 | 1.87× | — | ||
| Q1 24 | 2.00× | 0.23× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | $17.3M |
| 自由现金流经营现金流 - 资本支出 | $14.4M | $12.4M |
| 自由现金流率自由现金流/营收 | 19.1% | 20.2% |
| 资本支出强度资本支出/营收 | 0.0% | 8.1% |
| 现金转化率经营现金流/净利润 | — | 2.74× |
| 过去12个月自由现金流最近4个季度 | $41.7M | $12.3M |
8季度趋势，按日历期对齐
经营现金流PBYIPPIH
| Q4 25 | $14.4M | $17.3M | ||
| Q3 25 | $9.7M | $-2.0M | ||
| Q2 25 | $14.1M | $733.0K | ||
| Q1 25 | $3.6M | $6.0M | ||
| Q4 24 | $15.6M | $5.2M | ||
| Q3 24 | $11.0M | $2.8M | ||
| Q2 24 | $1.0M | $-73.0K | ||
| Q1 24 | $11.2M | $7.1M |
自由现金流PBYIPPIH
| Q4 25 | $14.4M | $12.4M | ||
| Q3 25 | $9.7M | $-4.6M | ||
| Q2 25 | $14.1M | $-194.0K | ||
| Q1 25 | $3.6M | $4.7M | ||
| Q4 24 | $15.6M | $4.8M | ||
| Q3 24 | $11.0M | $2.2M | ||
| Q2 24 | $1.0M | $-662.0K | ||
| Q1 24 | — | $4.2M |
自由现金流率PBYIPPIH
| Q4 25 | 19.1% | 20.2% | ||
| Q3 25 | 17.7% | -9.6% | ||
| Q2 25 | 26.8% | -0.4% | ||
| Q1 25 | 7.7% | 10.5% | ||
| Q4 24 | 26.4% | 11.6% | ||
| Q3 24 | 13.7% | 5.8% | ||
| Q2 24 | 2.1% | -1.9% | ||
| Q1 24 | — | 10.5% |
资本支出强度PBYIPPIH
| Q4 25 | 0.0% | 8.1% | ||
| Q3 25 | 0.0% | 5.3% | ||
| Q2 25 | 0.0% | 2.0% | ||
| Q1 25 | 0.1% | 2.9% | ||
| Q4 24 | 0.0% | 0.8% | ||
| Q3 24 | 0.0% | 1.7% | ||
| Q2 24 | 0.0% | 1.7% | ||
| Q1 24 | 0.0% | 7.2% |
现金转化率PBYIPPIH
| Q4 25 | — | 2.74× | ||
| Q3 25 | 1.10× | -2.40× | ||
| Q2 25 | 2.41× | 0.15× | ||
| Q1 25 | 1.21× | 3.42× | ||
| Q4 24 | — | 2.07× | ||
| Q3 24 | 0.54× | 0.86× | ||
| Q2 24 | — | -0.05× | ||
| Q1 24 | — | 0.82× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
